ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 730460 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 730460; 2) Community: the network communities that were significantly associated with the response to NSC 730460; 3) Molecule: the relationships between components within communities and NSC 730460; 4) MDR: the compounds that were significantly associated with the NSC 730460.

NSC Compound Enrichment Correlation
NSC 6926 Null 0.035202825328704 0.42985501
NSC 711077 Null 0.035202825328704 0.16724294
NSC 715481 Null 0.035202825328704 0.092557466
NSC 718781 Erlotinib hydrochloride 0.035202825328704 -0.14444302
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.035202825328704 0.26028371
NSC 726217 Combretastatin A4-analogue 0.035202825328704 0.28218822
NSC 728078 2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide 0.035202825328704 0.5051325
NSC 731701 1[(4-n-butyloxyCarbonyl)piperazine-1-yl]diazene-1-ium-1,2-di olate 0.0352028253287042 0.07059265
NSC 731704 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. 0.0352028253287042 0.3921505
NSC 732205 Null 0.0352028253287042 0.43011273
Total:151  Current:113    [First] [Prev] [Next] [Last]